| SEGMENT REPORTING |
NOTE
8 – SEGMENT REPORTING
Commencing
2020, the operations of the Company are conducted through three different core activities: Breast Cancer Test (TM-B1, TM-B2), Alzheimer
and COVID-19 testing, each of which are operating segments. These activities also represent the reportable segments of the Group.
The
reportable segments are viewed and evaluated separately by Company management, since the marketing strategies, processes and expected
long term financial performances of the segments are different.
| B. |
Information
about reported segment profit or loss and assets |
SCHEDULE
OF INFORMATION ABOUT REPORTED SEGMENT PROFIT OR LOSS AND ASSETS
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
COVID-19 |
|
|
|
|
|
|
|
| |
|
Breast
Cancer Test |
|
|
Alzheimer |
|
|
Testing
and related products |
|
|
|
|
|
Total |
|
| |
|
Unaudited |
|
| Nine months ended September
30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revenues |
|
|
- |
|
|
|
- |
|
|
|
6,292 |
|
|
|
- |
|
|
|
6,292 |
|
| Operating gain (loss) |
|
|
(1,352 |
) |
|
|
- |
|
|
|
1,061 |
|
|
|
(7,639 |
) |
|
|
(7,930 |
) |
| Unallocated amounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Financing expenses,
net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(11,735 |
) |
|
|
(11,735 |
) |
| Other
losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(396 |
) |
|
|
(396 |
) |
| Share
in losses of affiliated companies accounted for under equity method, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60 |
|
|
|
60 |
|
| Net loss |
|
|
(1,352 |
) |
|
|
- |
|
|
|
1,061 |
|
|
|
(19,710 |
) |
|
|
(20,001 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
COVID-19 |
|
|
|
|
|
|
|
| |
|
Breast
Cancer Test |
|
|
|
|
|
Testing
and related products |
|
|
Un-allocated |
|
|
Total |
|
| |
|
Unaudited |
|
| Nine
months ended September 30, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revenues |
|
|
- |
|
|
|
- |
|
|
|
7,773 |
|
|
|
- |
|
|
|
7,773 |
|
| Operating gain (loss) |
|
|
(4,685 |
) |
|
|
- |
|
|
|
(1,003 |
) |
|
|
- |
|
|
|
(5,688 |
) |
| Unallocated
amounts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Financing
expenses, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(17,360 |
) |
|
|
(17,360 |
) |
| Share
in losses of affiliated companies accounted for under equity method, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,499 |
) |
|
|
(1,499 |
) |
| Net loss |
|
|
(4,685 |
) |
|
|
- |
|
|
|
(1,003 |
) |
|
|
(18,859 |
) |
|
|
(24,547 |
) |
The
evaluation of performance is based on the operating income of each of the three reportable segments.
Accounting
policies of the segments are the same as those described in the accounting policies applied in the consolidated financial statements.
Due
to the reportable segments’ nature, there have been no inter-segment sales or transfers during the reported periods.
Financing
expenses, net and the share of the Company in losses of affiliated companies were not allocated to the reportable segments, since these
items are carried and evaluated on the enterprise level.
Management
has determined that none of the equity method investees is eligible to be considered as reportable segment as they do not meet the criteria
in ASC Topic 280-10-50 (or they did not commence their operations).
TODOS
MEDICAL LTD.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
(U.S.
dollars in thousands)
|
C. |
Revenues
by geographic region are as follows: |
SUMMARY
OF REVENUES BY GEOGRAPHIC REGION
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| |
|
Nine
months period ended September
30,
|
|
|
Three
months period ended September
30,
|
|
| |
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
| |
|
Unaudited |
|
|
Unaudited |
|
| Israel |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
| United
States |
|
|
6,292 |
|
|
|
7,773 |
|
|
|
1,914 |
|
|
|
1,010 |
|
| Total |
|
$ |
6,292 |
|
|
$ |
7,773 |
|
|
$ |
1,914 |
|
|
$ |
1,010 |
|
NOTE
8 – SEGMENT REPORTING (continue)
| D. |
Property
and equipment, net, by geographic areas: |
| |
|
2022 |
|
|
2021 |
|
| |
|
As
of September
30,
|
|
|
As
of
December
31,
|
|
| |
|
2022 |
|
|
2021 |
|
| |
|
Unaudited |
|
| Israel |
|
$ |
25 |
|
|
$ |
34 |
|
| United States |
|
|
1,573 |
|
|
|
2,011 |
|
| Property
and equipment, net |
|
$ |
1,598 |
|
|
$ |
2,045 |
|
SCHEDULE
OF MAJOR CUSTOMER
| |
|
2022 |
|
|
2021 |
|
| |
|
As of September
30, |
|
| |
|
2022 |
|
|
2021 |
|
| Client A |
|
|
- |
|
|
|
54.3
|
% |
| Client B |
|
|
11.5 |
% |
|
|
7.3 |
% |
| Client C |
|
|
1.2 |
% |
|
|
11.4 |
% |
| Client D |
|
|
8.0 |
% |
|
|
0.2 |
% |
| Total |
|
|
20.7 |
% |
|
|
81.9 |
% |
|